Literature DB >> 2921231

Rat pituitary tumor cells in serum-free culture. I. Selection of thyroid hormone-responsive and autonomous cells.

T L Riss1, B H Stewart, D A Sirbasku.   

Abstract

The growth of GH4C1, GH3, GH1, and GH3C15 rat pituitary tumor cell lines was studied in a serum-free medium (designated TRM-1) formulated with 1:1 (vol/vol) mixture of Ham's F12 nutrient mixture and Dulbecco's modified Eagle's medium (F12-DME) containing 15 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 50 micrograms/ml gentamicin supplemented with 10 micrograms/ml bovine insulin, 10 micrograms/ml human transferrin (Tf), 10 ng/ml selenous acid, 10 nM 3,5,3'-triiodothyronine (T3), 50 microM ethanolamine (Etn), and 500 micrograms/ml bovine serum albumin. Of the lines evaluated, only the GH1 failed to grow in TRM-1. Passage of the GH4C1 and GH3 lines from serum-containing medium into TRM-1 caused an initial selection resulting in cells that grew progressively at higher rates and finally were maintained indefinitely in TRM-1. These populations showed a requirement for supraphysiologic concentrations of T3 (1.0 to 10 nM). After adaptation of the GH4C1 line in TRM-1 for greater than or equal to 20 generations, removal of components gave a less complex mixture containing 15 mM HEPES, 50 micrograms/ml gentamicin, 10 micrograms/ml Tf, 10 nM T3, and 50 microM Etn (designated TRM-2) that supported serial passage of the cells. Under these conditions, thyroid hormone dependence was lost progressively. When T3 was removed from TRM-2 adapted cells, a third population was selected that no longer required thyroid hormones and was only slightly stimulated by T3. These studies demonstrated that the combination of serum-containing and serum-free conditions can be used to select pituitary cell populations that a) required both serum-factor(s) and T3 for optimum growth, b) required supraphysiologic concentrations of T3 without serum proteins other than Tf and albumin, and c) were completely autonomous in that they proliferated in medium supplemented only with Tf and nutrients without necessity of other serum factor(s) or T3.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2921231     DOI: 10.1007/BF02626168

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  36 in total

1.  Thyroid hormone action: a cell-culture system responsive to physiological concentrations of thyroid hormones.

Authors:  H H Samuels; J S Tsai; R Cintron
Journal:  Science       Date:  1973-09-28       Impact factor: 47.728

2.  Growth in suspension culture of rat pituitary cells which produce growth hormone and prolactin.

Authors:  F C Bancroft; A H Tashjian
Journal:  Exp Cell Res       Date:  1971-01       Impact factor: 3.905

3.  Hormonal growth control of cells in culture.

Authors:  I Hayashi; J Larner; G Sato
Journal:  In Vitro       Date:  1978-01

4.  Epidermal growth factor and expression of specific genes: effects on cultured rat pituitary cells are dissociable from the mitogenic response.

Authors:  L K Johnson; J D Baxter; I Vlodavsky; D Gospodarowicz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

5.  Regulation of growth hormone mRNA synthesis by 3,5,3'-triiodo-L-thyronine in cultured growth hormone-producing rat pituitary tumor cells (GC cells). Dissociation between nuclear iodothyronine receptor concentration and growth hormone mRNA synthesis during the deoxyribonucleic acid synthesis phase of the cell cycle.

Authors:  M H Kumara-Siri; M I Surks
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

6.  Thyroid hormone action: in vitro characterization of solubilized nuclear receptors from rat liver and cultured GH1 cells.

Authors:  H H Samuels; J S Tsai; J Casanova; F Stanley
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

7.  Control of cell growth. III. Direct mitogenic effect of thyroid hormones on an estrogen-dependent rat pituitary tumor cell line.

Authors:  W L Kirkland; J M Sorrentino; D A Sirbasku
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

8.  Control of cell growth. I. Estrogen-dependent growth in vivo of a rat pituitary tumor cell line.

Authors:  J M Sorrentino; W L Kirkland; D A Sirbasku
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

9.  Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine. An explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active thyroid hormone.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

10.  Thyroid hormone stimulates de novo growth hormone synthesis in cultured GH1 cells: evidence for the accumulation of a rate limiting RNA species in the induction process.

Authors:  H H Samuels; L E Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

View more
  5 in total

1.  Iron is deleterious to hormone-responsive pituitary cell growth in serum-free defined medium.

Authors:  H Sato; J E Eby; D A Sirbasku
Journal:  In Vitro Cell Dev Biol       Date:  1991-08

Review 2.  Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes.

Authors:  Josiah Ochieng; Gladys Nangami; Amos Sakwe; Cierra Moye; Joel Alvarez; Diva Whalen; Portia Thomas; Philip Lammers
Journal:  Int J Mol Sci       Date:  2018-07-29       Impact factor: 5.923

3.  Rat pituitary tumor cells in serum-free culture. II. Serum factor and thyroid hormone requirements for estrogen-responsive growth.

Authors:  T L Riss; D A Sirbasku
Journal:  In Vitro Cell Dev Biol       Date:  1989-02

4.  Thyroid hormone and apotransferrin regulation of growth hormone secretion by GH1 rat pituitary tumor cells in iron restricted serum-free defined medium.

Authors:  D A Sirbasku; R Pakala; H Sato; J E Eby
Journal:  In Vitro Cell Dev Biol       Date:  1992-01

5.  Characterization of a rat anterior pituitary cell bioassay.

Authors:  A H Balen; J Er; B Rafferty; M Rose
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-04       Impact factor: 2.416

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.